oral medication glp 1 Pills vs. Pens: The Ultimate Comparison of and Injectable GLP-1s FDA Approves Oral Semaglutide: First

A novel dual GLP-1/GIP receptor agonist alleviates cognitive decline by re-sensitizing insulin signaling in the Alzheimer icv

But they do basically the same thing

This evolution will be driven by expanded clinical evidence, development of cardiovascular-specific treatment protocols, and modification of reimbursement criteria to include primary prevention of cardiovascular events in high-risk populations regardless of weight loss magnitude

Kidney and Renal Complications: Ozempic has been linked to acute kidney injuries, particularly in those with pre-existing kidney issues, potentially exacerbated by dehydration from gastrointestinal side effects

[DOI] [PubMed] [Google Scholar] 44.Raskin P, Mohan A

And, now theres even a microtrend within the weight-loss drug community: microdosing